Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Anixa Biosciences | ANIX | Aug 30, 2024 | 3.34 | +0.60 |
Annaly Capital Management | NLY | Aug 30, 2024 | 20.16 | +0.55 |
Annaly Capital Management F Pref | NLY-F | Aug 30, 2024 | 25.27 | -2.24 |
Annaly Capital Management G Pref | NLY-G | Aug 30, 2024 | 25.01 | -2.34 |
Annaly Capital Management I Pref | NLY-I | Aug 30, 2024 | 25.17 | -2.33 |
Annexon | ANNX | Aug 30, 2024 | 5.70 | -3.88 |
Annovis Bio | ANVS | Aug 30, 2024 | 8.46 | -4.08 |
ANSYS | ANSS | Aug 30, 2024 | 321.42 | +0.45 |
Antelope Enterprise | AEHL | Aug 30, 2024 | 2.34 | +13.04 |
Anterix | ATEX | Aug 30, 2024 | 35.47 | +0.80 |
Antero Midstream | AM | Aug 30, 2024 | 14.87 | +0.95 |
Antero Resources | AR | Aug 30, 2024 | 26.99 | +0.33 |
Anywhere Real Estate | HOUS | Aug 30, 2024 | 4.89 | -2.40 |
Aon | AON | Aug 30, 2024 | 343.72 | +0.08 |
APA | APA | Aug 30, 2024 | 28.49 | -2.90 |
Apartment Investment and Management | AIV | Aug 30, 2024 | 9.30 | -0.53 |
Apellis Pharmaceuticals | APLS | Aug 30, 2024 | 38.90 | +0.46 |
APi Group | APG | Aug 30, 2024 | 35.55 | +0.99 |
Apogee Enterprises | APOG | Aug 30, 2024 | 66.78 | +0.63 |
Apogee Therapeutics | APGE | Aug 30, 2024 | 51.17 | +3.52 |
Apollo Commercial Real Estate Finance | ARI | Aug 30, 2024 | 10.59 | +0.47 |
Apollo Global Management | APO | Aug 30, 2024 | 115.73 | +2.18 |
Apollomics A | APLM | Aug 30, 2024 | 0.12 | -5.95 |
AppFolio A | APPF | Aug 30, 2024 | 231.99 | -0.06 |
Appian A | APPN | Aug 30, 2024 | 32.44 | -0.12 |
Apple | AAPL | Aug 30, 2024 | 229.00 | -0.34 |
Apple Hospitality REIT | APLE | Aug 30, 2024 | 14.44 | +0.77 |
Applied Digital | APLD | Aug 30, 2024 | 3.65 | -4.45 |
Applied DNA Sciences | APDN | Aug 30, 2024 | 1.91 | -13.57 |
Applied Industrial Technologies | AIT | Aug 30, 2024 | 205.12 | +0.83 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.